Is the price fair?
What OPK's price assumes
OPKO Health, Inc. did not earn a profit over the last twelve months, so it has no trailing P/E and the price is read against sales instead: 1.49× revenue.
1.49
Price / sales · no P/E: the last twelve months did not end in a profit
- Price / book
- 0.72
Price / book · as of 2026-Q1
- EV / sales
- 1.51
EV / sales
Details›
- Price / book2026-Q1
- 0.72
- EV / EBIToperating margin −17%: the multiple describes the denominator
- not meaningful
- EV / sales2026-Q1
- 1.51
- Market capitalisation
- $1.07B
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Diagnostics & Research
Ranks #15 of 29 by Smart Score